Previous studies have demonstrated that PTEN‐Akt signaling pathway contributes to the carcinogenesis of variant cancers, such as pancreatic cancer, hepatocellular carcinoma, breast carcinoma, and gastric carcinoma.30, 31, 32, 33. This evidence concerns the gene PTEN and familial pancreatic carcinoma.